NCT03883178View on ClinicalTrials.gov

New Endoscopic Minimal Invasive Approach for Pudendal Nerve and Inferior Cluneal Nerve Neurolysis: a Clinical Study

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 16, 2017

Primary Completion Date

January 29, 2019

Study Completion Date

January 29, 2019

Conditions
PudendopathieClunealgie
Interventions
PROCEDURE

Minimal-invasive endoscopic transgluteal approach

Every patient, suffering from a pudendopathie or clunealgie, conform the Nantes criteria, and who are candidates for a surgical treatment through the transgluteal open approach, will be asked their permission to perform the procedure through a minimal-invasive endoscopic transgluteal approach.

Trial Locations (1)

1020

CHU Brugmann, Brussels

All Listed Sponsors
lead

Katleen JOTTARD

OTHER

NCT03883178 - New Endoscopic Minimal Invasive Approach for Pudendal Nerve and Inferior Cluneal Nerve Neurolysis: a Clinical Study | Biotech Hunter | Biotech Hunter